Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lyell syndrome and its attributability to medications: methodological problems].

J C Roujeau1

  • 1Service de dermatologie, Hôpital Henri Mondor, Créteil.

Allergie Et Immunologie
|June 1, 1990
PubMed
Summary

Establishing a causal link between Lyell's syndrome and specific drugs is methodologically challenging. Rigorous risk calculation requires prospective epidemiological studies, not individual case assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

The British journal of dermatology·2013
Same author

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients.

The British journal of dermatology·2013
Same author

Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms.

The British journal of dermatology·2013
Same author

The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.

The British journal of dermatology·2012
Same author

The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid.

Dermatology (Basel, Switzerland)·2012
Same author

Grover's disease in a renal transplant patient, after hemodialysis renewal.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2012

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Epidemiology

Context:

  • Lyell's syndrome, a severe drug reaction, presents diagnostic challenges in establishing causality.
  • Individual drug-reaction association relies on probability and chronological criteria due to lack of definitive tests.
  • Estimating population-level drug risk is hindered by difficulties in determining patient exposure denominators.

Purpose:

  • To highlight the methodological complexities in attributing Lyell's syndrome to specific drugs.
  • To discuss the limitations of current methods for establishing drug causality.
  • To emphasize the need for robust epidemiological studies for accurate risk assessment.

Summary:

  • Causal links between drugs and Lyell's syndrome are difficult to establish due to reliance on probabilistic, chronological criteria and absence of reliable diagnostic tests.
  • Estimating population-level risk is problematic, often relying on indirect sales data for patient exposure denominators.
  • Prospective case-control epidemiological studies are essential for rigorous drug risk calculation in Lyell's syndrome etiology, though they don't resolve individual case association.

Impact:

  • Informs pharmacovigilance strategies for adverse drug reaction monitoring.
  • Highlights the importance of rigorous study design in drug safety research.
  • Aids regulatory bodies in assessing drug-related risks and informing clinical practice.

Related Experiment Videos